22nd Century Group logo.jpg
22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021
May 06, 2021 06:00 ET | 22nd Century Group, Inc
Key Business and Financial Highlights 22nd Century is advancing commercial opportunities across $1.3 trillion global addressable markets in tobacco, hemp/cannabis, and a third plant-based...
22nd Century Group logo.jpg
22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production
May 05, 2021 10:06 ET | 22nd Century Group, Inc
BUFFALO, N.Y., May 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine...
22nd Century Group logo.jpg
22nd Century Group and KeyGene Extend and Expand Plant Research Partnership
May 04, 2021 09:20 ET | 22nd Century Group, Inc
Updated Agreement Extends Exclusive Program to Create Valuable, New Hemp/Cannabis Varieties and Expands Collaboration to Include 22nd Century’s Two Other Plant Franchises Partnerships Will Enable...
22nd Century Group logo.jpg
22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles “Still on the Table”
April 30, 2021 11:05 ET | 22nd Century Group, Inc
Applauds Decisive Move and Commitment by FDA to Advance Rule Banning Menthol As First Step to Reduce Addiction, Improve Quitting, Reduce Youth Initiation and Reduced Disparities; Movement on Nicotine...
22nd Century Group logo.jpg
Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities
April 29, 2021 06:50 ET | 22nd Century Group, Inc
BUFFALO, N.Y., April 29, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, very low nicotine...
22nd Century Group logo.jpg
22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
April 26, 2021 10:06 ET | 22nd Century Group, Inc
To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine Content Research Cigarettes for Numerous Independent Scientific Studies Research on Nicotine Content Reduction in Cigarettes...
22nd Century Group logo.jpg
22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results
April 22, 2021 10:35 ET | 22nd Century Group, Inc
BUFFALO, N.Y., April 22, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company that is focused on tobacco harm reduction, very low...
22nd Century Group logo.jpg
22nd Century Group Issues Annual Letter to Shareholders
April 21, 2021 10:35 ET | 22nd Century Group, Inc
Company’s Confidence in MRTP Authorization is High; Launch of VLN® is Only the Beginning for Tobacco Franchise Key Partnerships to Drive Differentiation and Value; Accelerated Delivery of Disruptive,...
22nd Century Group logo.jpg
22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.
April 20, 2021 16:00 ET | 22nd Century Group, Inc
Company’s Confidence Continues to Grow on Implementation of Proposed Nicotine Cap and Menthol Ban Company is Fully Prepared to Launch its VLN® Reduced Nicotine Content Cigarettes; Willing to License...
22nd Century Group logo.jpg
22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan
April 15, 2021 17:56 ET | 22nd Century Group, Inc
BUFFALO, N.Y., April 15, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low...